Who are iRhythm's investors?

iRhythm's investors include Kaiser Permanente Ventures, Norwest Venture Partners, New Leaf Venture Partners, St. Jude Medical.

How much funding has iRhythm raised?

iRhythm has disclosed $49.5M raised across 2 rounds.

Where is iRhythm headquartered?

iRhythm is headquartered in San Francisco, US.

iRhythm

NASDAQ: IRTC

San Francisco, US · Founded 2006 · Delaware corporation · 1,905 employees on LinkedIn · 4 known investors

Find your way into iRhythm

Paths you didn't know you had: your email and LinkedIn already hold routes to the iRhythm team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.

AI & Machine Learning Healthtech Medical Devices

Founders & leadership

Kevin M. King Board Member2012–2022Kevin King is President and CEO of iRhythm, a maker of wearable cardiac monitoring devices and AI-powered diagnostic services. He has led both public and private healthcare companies across genetic analysis, information technology, healthcare services, and medical devices.

Shelly D. Guyer CFO / Executive Vice President, Finance and Administration2008–2012Shelly D. Guyer is an executive with over 30 years of experience in finance and life sciences, including roles as a venture capitalist and Chief Sustainability Officer, and has held senior positions at companies including Veracyte and Invitae where she managed capital raising and financial strategy.

William F. WillisExecutive

Judith LenaneExecutive

Steve Johnson Chief Operating Officer2011–2012Steve Johnson is an executive at iRhythm Technologies with experience in medical device product development, manufacturing, and quality systems for implantable, disposable, and reusable devices. He has led cross-functional teams through clinical trials and market launches of diagnostic and therapeutic medical devices.

Board

Tiba Aynechi Member Board of Directors2014–2017General Partner at Norwest Venture Partners

Joshua L. GreenBoard director

Casper de Clercq Board Director2013–2017General Partner at Norwest Venture Partners

Chris E. Grant Board directorCo-Founder & Chief Operating Officer and Executive Vice President, The Permanente Federation LLC at Kaiser Permanente Ventures

William N. StarlingBoard director

Vijay K. LathiBoard directorManaging Director at New Leaf Venture Partners

Sam E. BraschBoard director

Investors · 4

Kaiser Permanente Ventureslisted by Kaiser Permanente VenturesSan Francisco · $2M – $5M

How we know: Kaiser Permanente Ventures's portfolio page · the S-1 prospectus · open dataset · 5k.vc investor directory · Not right? Tell us

Norwest Venture Partnerslisted by Norwest Venture PartnersMenlo Park · $10M – $30Mvia Tiba Aynechi · board

How we know: the S-1 prospectus · board seat on SEC Form D · Not right? Tell us

New Leaf Venture PartnersinferredNew Yorkvia Vijay Lathi · board

How we know: board seat on SEC Form D · Not right? Tell us

St. Jude Medicalreported

How we know: the S-1 prospectus · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$49.5M disclosed across 2 rounds · 2011–2014

▶$27.3MraisedMar 2015 · 10 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kevin M. KingExecutive Officer, Director
Tiba AynechiDirector
Joshua L. GreenDirector
Casper de ClercqDirector
Chris E. GrantDirector
William N. StarlingDirector
Raymond ScottDirector
Vijay K. LathiDirector

Offering amount: $29.5M
Amount sold: $27.3M
Minimum investment: $1
First sale: May 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$22.1MraisedJan 2012 · 10 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Roberta R. KatzDirector
Shelly D. GuyerExecutive Officer
William N. StarlingDirector
William F. WillisExecutive Officer, Director
Sam E. BraschDirector
Joshua L. GreenDirector
R. Hardwin MeadDirector
Judith LenaneExecutive Officer
Steve JohnsonExecutive Officer
Vijay K. LathiDirector

Offering amount: $22.1M
Amount sold: $22.1M
First sale: Apr 2011
Incorporated: Corporation, Delaware
Federal exemptions: 06

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events

$359.1Mvaluation at IPOOct 2016 · $17.00/share · 424B4

filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

3 people who came through Irhythmtech went on to found or lead other companies.

Mudit K. JainVenture Capital InvestorFounded ShiraTronics Peter LivingstonFirst EngineerFounded Unpopular Ventures Doug BiehnVice President, CommercialFounded Octave

Related companies · 2

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies working in the same space as iRhythm.

Frequently asked questions

What does iRhythm do?: iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
Who are iRhythm's investors?: iRhythm's investors include Kaiser Permanente Ventures, Norwest Venture Partners, New Leaf Venture Partners, St. Jude Medical.
How much funding has iRhythm raised?: iRhythm has disclosed $49.5M raised across 2 rounds.
Where is iRhythm headquartered?: iRhythm is headquartered in San Francisco, US.